Longevity

November 14, 2018

Molecular therapy for aging-associated diseases and Lifespan extension: Rosuvastatin, an anti-dyslipidemic drug used to treat lower cholesterol levels and cardiovascular disease,, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer and aging via down regulation of its target gene, 14/November/2018, 11.48 pm

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and […]
November 7, 2018

Lengthening the lifespan of mighty humans with a tiny probiotic Bifidobacterium lactis (BL) HY8101: Probiotic Bifidobacterium lactis (BL) HY8101 may  increase insulin sensitivity, slow down cardiac aging, and increase lifespan, via up-regulation of BubR1 and others longevity-promoting genes, 7/November/2018, 11.26 pm

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston, USA; […]
November 1, 2018

Repurposing the anti-pulmonary hypertensive drug into a longevity-promoting drug: Valsartan (trade name: Diovan), an anti-pulmonary hypertensive drug, increases NMN/NAD levels, decreases interaction of DBC1 with PARP1, increases PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 1/November/2018, 3.18 pm

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and […]
October 28, 2018

Lengthening the lifespan of mighty humans with tiny probiotic Clostridium Butyricum: Probiotic Clostridium Butyricum CGMCC0313.1 may  increase insulin sensitivity, slow down cardiac aging, and increase lifespan, via up-regulation of BubR1 and others longevity-promoting genes, 28/October/2018, 11.00 pm

 What they say: Introduction:  A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston, USA; […]